Top Heal Care Stocks To Buy Right Now


"Trust the process."   That's what highly regarded Florida State University football coach Jimbo Fisher tells his players, over and over again. Trust the system we've created here. Learn it, and you'll be successful.   Fisher is a brilliant gridiron tactician who has built a first-class, state-of-the-art training and development system. My nephew is a redshirt freshman on this year's team… And he has nothing but high praise for "the process," which is drilled into them during daily six-hour practice sessions.   A superior process and greatness often go hand in hand in athletics. This is also true for investing.   Serious investors would be wise to learn to trust the process that generates winning investment results…   I'm referring specifically to the process recently laid out in "Reflections on the 10 Attributes of Great Investors," an essay by Michael J. Mauboussin. He's a prominent value investor, author, and longtime adjunct professor at Columbia University.

Top Heal Care Stocks To Buy Right Now: Carnival Corporation(CCL)


Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    Below, we’ll highlight a few companies that offer investors a healthy mix of these important characteristics. Read on to see why the stocks of Procter & Gamble (NYSE:PG), Garmin (NASDAQ:GRMN), and Carnival (NYSE:CCL) belong on your income investing watch list.

  • [By ]

    6. Carnival (NYSE: CCL)
    My favorite company on the list. The cruise ship company is trading higher by nearly 8% over the last year and is currently yielding a respectable 3%.

  • [By Demitrios Kalogeropoulos]

    This is a good time to be in the cruise business, especially if you’re the industry’s dominant player. Back in late March, Carnival (NYSE:CCL) announced its best sales growth performance since 2011 as customers packed its fleet and made heavy use of optional onboard amenities like spas and premium dining.

  • [By Chris Lange]

    Carnival Corp. (NYSE: CCL) fiscal first-quarter report is scheduled for Thursday. The consensus forecast is $0.43 in EPS on $4.11 billion in revenue. Shares closed at $66.91 apiece. The consensus price target is $76.94, and the 52-week range is $57.09 to $72.70.

  • [By Garrett Baldwin]

    Three Stocks to Watch Today: NKE, KORS, GE

    Shares of Nike Inc. (NYSE: NKE) are on the move ahead of today’s earnings report. Wall Street expects that the apparel giant will report earnings per share of $0.62 on top of $9.87 billion in revenue. Investors will be hanging on every word of the conference call as markets weigh the success of the company’s latest ad campaign featuring Colin Kaepernick. In addition, investors will be curious if the firm received a boost by the Tour Championship victory over the weekend by Tiger Woods, who won his first golf tournament in five years. Michael Kors Holdings Ltd. (NYSE: KORS) just made another huge acquisition. According to reports, it purchased the iconic Gianni Versace brand in a deal worth $2.1 billion. The deal gives Kors a gateway to the high-end European luxury market. Shares of General Electric Co. (NYSE: GE) are sitting at nine-year lows as the company’s power business struggles. Shares hit their lowest levels since July 13, 2009 as the firm grapples with a failed gas turbine in Texas. The turbine’s failure fueled a stock downgrade by JPMorgan Chase & Co. (NYSE: GE) last week. Look for earnings reports from Carnival Corp. (NYSE: CCL), KB Home (NYSE: KBH), FactSet Research Systems Inc. (NYSE: FDS), Jabil Inc. (NYSE: JBL), Cintas Corp. (NASDAQ: CTAS), AAR Corp. (NYSE: AIR), Neogen Corp. (NASDAQ: NEOG), and IHS Markit Ltd. (NYSE: INFO).


    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By ]

    Investors should book a trip on Carnival Corp.’s (CCL) stock. 

    Shares of the cruise line known for its hot party scenes and general affordability, have tumbled 4% this year on multiple concerns. Chief among them is a coming industry uptick in new ships set to sail the waters. That has prompted Wall Street to fear a discount war among the major cruise lines, especially if the U.S. economy slows sharply in 2019 as many speculate.

Top Heal Care Stocks To Buy Right Now: Ideal Power Inc.(IPWR)


Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    Here are last week’s top-performing penny stocks:

    Penny Stock Sector Current Share Price Last Week’s Gain
    Electra Meccanica Vehicles Corp. (NASDAQ: SOLO) Consumer Goods $4.39 259.84%
    Gridsum Holding Inc. (NASDAQ: GSUM) Technology $4.32 108.70%
    Sky Solar Holdings Ltd. (NASDAQ: SKYS) Utilities $1.08 89.47%
    Conformis Inc. (NASDAQ: CFMS) Healthcare $1.26 75.00%
    Ideal Power Inc. (NASDAQ: IPWR) Industrial Goods $0.52 56.73%
    ADMA Biologics Inc. (NASDAQ: ADMA) Healthcare $4.22 52.35%
    CAS Medical Systems Inc. (NASDAQ: CASM) Healthcare $2.41 51.57%
    Arcimoto Inc. (NASDAQ: FUV) Consumer Goods $4.88 50.15%
    Adomani Inc. (NASDAQ: ADOM) Consumer Goods $0.38 49.94%
    Huttig Building Products Inc. (NASDAQ: HBP) Services $3.41 47.62%


    Can’t-Miss Opportunity: Renowned Author of Best-Selling Investment “Bible” Just Released His Newest Pick

  • [By Max Byerly]

    Headlines about Ideal Power (NASDAQ:IPWR) have been trending somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Ideal Power earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave media headlines about the industrial products company an impact score of 46.8284728476176 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Logan Wallace]

    Ideal Power (NASDAQ: IPWR) and Hollysys Automation Technologies (NASDAQ:HOLI) are both small-cap industrial products companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ideal Power (IPWR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Here are some of the news headlines that may have effected Accern Sentiment’s rankings:

    Get Ideal Power alerts:

    Ideal Power (IPWR) Expected to Announce Quarterly Sales of $390,000.00 (americanbankingnews.com) -$0.15 EPS Expected for Ideal Power (IPWR) This Quarter (americanbankingnews.com) Ideal Power Receives 1.1 Megawatt Purchase Order for its SunDial™ Plus Inverters (investingnews.com) Ideal Power Receives 1.1 Megawatt Purchase Order for its SunDial™ Plus Inverters from NEXTracker for One of the Largest Solar-and-Storage Installations in Iowa (finance.yahoo.com)


    A number of equities analysts have commented on the stock. Zacks Investment Research raised shares of Ideal Power from a “hold” rating to a “buy” rating and set a $1.50 price target for the company in a research note on Wednesday, January 10th. HC Wainwright reissued a “buy” rating and issued a $4.00 price target on shares of Ideal Power in a research note on Wednesday, March 7th. Roth Capital reissued a “hold” rating and issued a $1.00 price target on shares of Ideal Power in a research note on Wednesday, March 7th. Finally, B. Riley cut shares of Ideal Power from a “buy” rating to a “neutral” rating and cut their price target for the stock from $5.00 to $2.50 in a research note on Wednesday, March 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Ideal Power currently has a consensus rating of “Hold” and a consensus price target of $3.00.

Top Heal Care Stocks To Buy Right Now: Summer Infant Inc.(SUMR)


Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Summer Infant (SUMR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Summer Infant (NASDAQ:SUMR) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday.

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to

Top Heal Care Stocks To Buy Right Now: County Bancorp, Inc.(ICBK)


Advisors’ Opinion:

  • [By Max Byerly]

    Middlefield Banc (NASDAQ: ICBK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings.

  • [By Max Byerly]

    Southern National Banc. of Virginia (NASDAQ: ICBK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.

  • [By Stephan Byrd]

    County Bancorp Inc (NASDAQ:ICBK) President Timothy J. Schneider sold 1,000 shares of the stock in a transaction on Monday, June 4th. The shares were sold at an average price of $27.55, for a total value of $27,550.00. Following the completion of the sale, the president now owns 113,882 shares in the company, valued at $3,137,449.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

  • [By Logan Wallace]

    County Bancorp (NASDAQ:ICBK) has received an average recommendation of “Hold” from the six research firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $32.75.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on County Bancorp (ICBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com